DaVita Inc.

NYSE:DVA Stock Report

Market Cap: US$11.9b

DaVita Management

Management criteria checks 3/4

DaVita's CEO is Javier Rodriguez, appointed in Jun 2019, has a tenure of 5.42 years. total yearly compensation is $6.71M, comprised of 21% salary and 79% bonuses, including company stock and options. directly owns 1.02% of the company’s shares, worth $121.44M. The average tenure of the management team and the board of directors is 5.1 years and 4.3 years respectively.

Key information

Javier Rodriguez

Chief executive officer

US$6.7m

Total compensation

CEO salary percentage21.0%
CEO tenure5.4yrs
CEO ownership1.0%
Management average tenure5.1yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

Is DaVita (NYSE:DVA) A Risky Investment?

Oct 29
Is DaVita (NYSE:DVA) A Risky Investment?

An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 47% Undervalued

Sep 16
An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 47% Undervalued

DaVita Inc.'s (NYSE:DVA) Shares Lagging The Market But So Is The Business

Sep 01
DaVita Inc.'s (NYSE:DVA) Shares Lagging The Market But So Is The Business

DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet

Jul 02
DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet

Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Jun 19
Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Are DaVita Inc. (NYSE:DVA) Investors Paying Above The Intrinsic Value?

Jun 04
Are DaVita Inc. (NYSE:DVA) Investors Paying Above The Intrinsic Value?

Returns On Capital At DaVita (NYSE:DVA) Have Hit The Brakes

May 22
Returns On Capital At DaVita (NYSE:DVA) Have Hit The Brakes

DaVita Stock Is A Hold As It Expands In Latin America

Mar 18

Market Might Still Lack Some Conviction On DaVita Inc. (NYSE:DVA) Even After 27% Share Price Boost

Mar 13
Market Might Still Lack Some Conviction On DaVita Inc. (NYSE:DVA) Even After 27% Share Price Boost

Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Mar 04
Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 16
DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent Results

Is DaVita (NYSE:DVA) Using Too Much Debt?

Feb 08
Is DaVita (NYSE:DVA) Using Too Much Debt?

DaVita: Assessing After The Rally

Dec 29

DaVita Inc.'s (NYSE:DVA) Subdued P/E Might Signal An Opportunity

Dec 24
DaVita Inc.'s (NYSE:DVA) Subdued P/E Might Signal An Opportunity

DaVita (NYSE:DVA) Has A Somewhat Strained Balance Sheet

Nov 08
DaVita (NYSE:DVA) Has A Somewhat Strained Balance Sheet

DaVita: Simple And Compelling After Sell-Off

Oct 26

Returns On Capital Signal Difficult Times Ahead For DaVita (NYSE:DVA)

Oct 25
Returns On Capital Signal Difficult Times Ahead For DaVita (NYSE:DVA)

DaVita: Continued Economic Hurdles, Market Expectations May Be Correct

Oct 05

Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?

Aug 14
Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?

DaVita (NYSE:DVA) Takes On Some Risk With Its Use Of Debt

Jul 31
DaVita (NYSE:DVA) Takes On Some Risk With Its Use Of Debt

DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold

Jul 21

Returns At DaVita (NYSE:DVA) Appear To Be Weighed Down

Jul 18
Returns At DaVita (NYSE:DVA) Appear To Be Weighed Down

DaVita Inc. (NYSE:DVA) Shares Could Be 41% Below Their Intrinsic Value Estimate

Jul 03
DaVita Inc. (NYSE:DVA) Shares Could Be 41% Below Their Intrinsic Value Estimate

What Is DaVita Inc.'s (NYSE:DVA) Share Price Doing?

May 01
What Is DaVita Inc.'s (NYSE:DVA) Share Price Doing?

These 4 Measures Indicate That DaVita (NYSE:DVA) Is Using Debt Extensively

Apr 17
These 4 Measures Indicate That DaVita (NYSE:DVA) Is Using Debt Extensively

Investors Met With Slowing Returns on Capital At DaVita (NYSE:DVA)

Apr 03
Investors Met With Slowing Returns on Capital At DaVita (NYSE:DVA)

Are Investors Undervaluing DaVita Inc. (NYSE:DVA) By 40%?

Mar 08
Are Investors Undervaluing DaVita Inc. (NYSE:DVA) By 40%?

DaVita HealthCare Partners Q4 2022 Earnings Preview

Feb 21

Moon Capital - DaVita: A Recession-Resistant Cash Generating Machine

Feb 08

Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

Jan 24
Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

Is DaVita (NYSE:DVA) A Risky Investment?

Jan 09
Is DaVita (NYSE:DVA) A Risky Investment?

DaVita: Shares Still Appear Cheap After Outlook Cut, Technicals Suggest Caution

Dec 12

DaVita Q3 2022 Earnings Preview

Oct 27

Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

Oct 18
Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

CEO Compensation Analysis

How has Javier Rodriguez's remuneration changed compared to DaVita's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$828m

Jun 30 2024n/an/a

US$860m

Mar 31 2024n/an/a

US$816m

Dec 31 2023US$7mUS$1m

US$692m

Sep 30 2023n/an/a

US$596m

Jun 30 2023n/an/a

US$454m

Mar 31 2023n/an/a

US$500m

Dec 31 2022US$3mUS$1m

US$547m

Sep 30 2022n/an/a

US$680m

Jun 30 2022n/an/a

US$834m

Mar 31 2022n/an/a

US$903m

Dec 31 2021US$3mUS$1m

US$978m

Sep 30 2021n/an/a

US$984m

Jun 30 2021n/an/a

US$883m

Mar 31 2021n/an/a

US$791m

Dec 31 2020US$73mUS$1m

US$783m

Sep 30 2020n/an/a

US$832m

Jun 30 2020n/an/a

US$824m

Mar 31 2020n/an/a

US$816m

Dec 31 2019US$17mUS$1m

US$705m

Sep 30 2019n/an/a

US$623m

Jun 30 2019n/an/a

US$548m

Mar 31 2019n/an/a

US$551m

Dec 31 2018US$8mUS$900k

US$616m

Sep 30 2018n/an/a

US$617m

Jun 30 2018n/an/a

US$698m

Mar 31 2018n/an/a

US$652m

Dec 31 2017US$8mUS$900k

US$909m

Compensation vs Market: Javier's total compensation ($USD6.71M) is below average for companies of similar size in the US market ($USD12.87M).

Compensation vs Earnings: Javier's compensation has increased by more than 20% in the past year.

CEO

Javier Rodriguez (53 yo)

5.4yrs

Tenure

US$6,712,328

Compensation

Mr. Javier J. Rodriguez serves as an Independent Director at Gilead Sciences, Inc. since June 15, 2020. He has been Chief Executive Officer and Executive Director of DaVita Inc. since June 1, 2019. Mr. Rod...

Leadership Team

NamePositionTenureCompensationOwnership
Javier Rodriguez
CEO & Executive Director5.4yrsUS$6.71m1.02%
$ 121.4m
Joel Ackerman
CFO & Treasurer7.8yrsUS$6.87m0.11%
$ 13.5m
Kathleen Waters
Chief Legal & Public Affairs Officer8.5yrsUS$5.61m0.071%
$ 8.4m
James Hearty
Chief Compliance Officer6.7yrsUS$2.73m0.015%
$ 1.7m
David Maughan
Chief Operating Officerless than a yearno data0.0073%
$ 872.4k
Christopher Berry
Group VP & Chief Accounting Officer1.3yrsno datano data
Madhu Narasimhan
Chief Information Officerless than a yearno datano data
Nic Eliason
Group Vice President of Investor Relationsno datano datano data
Jessica Hergenreter
Chief People Officerless than a yearno datano data
Misha Palecek
Chief Transformation Officer of U.S. Kidney Care Businessno datano datano data
Jeffrey Giullian
Chief Medical Officer of Kidney Care4.8yrsno datano data
Partha Das
Chief Medical Officer of DaVita International6.3yrsno datano data

5.1yrs

Average Tenure

55yo

Average Age

Experienced Management: DVA's management team is seasoned and experienced (5.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Javier Rodriguez
CEO & Executive Director5.4yrsUS$6.71m1.02%
$ 121.4m
Charles Berg
Director17.7yrsUS$322.46k0.032%
$ 3.8m
Barbara Desoer
Independent Director9.1yrsUS$384.96k0.014%
$ 1.7m
Phyllis Yale
Independent Director8.3yrsUS$374.96k0.019%
$ 2.3m
Wendy Schoppert
Independent Director1.3yrsUS$106.86k0.0019%
$ 219.9k
Pamela Arway
Independent Chair15.5yrsUS$497.46k0.030%
$ 3.6m
Dennis Pullin
Independent Directorless than a yearno data0.00037%
$ 44.0k
Adam Schechter
Independent Director2.2yrsUS$334.96k0.0040%
$ 481.3k
Jason Hollar
Independent Director2.5yrsUS$364.96k0.0052%
$ 613.3k
Gregory Moore
Independent Director3.2yrsUS$355.89k0.0066%
$ 789.2k

4.3yrs

Average Tenure

61.5yo

Average Age

Experienced Board: DVA's board of directors are considered experienced (4.3 years average tenure).